MONOPAR THERAPEUTICS INC (MNPR) Stock Income Statement
NASDAQ:MNPR - Nasdaq - US61023L2079 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 17.66M | 8.83M | 10.54M | 9.13M | 6.51M | |||
| Research and Development | 13.68M | 5.60M | 7.59M | 6.49M | 4.07M | |||
| Selling, General, and Administrative Expenses | 3.98M | 3.23M | 2.95M | 2.63M | 2.44M | |||
| Operating Income | -17.66M | -8.83M | -10.54M | -9.13M | -6.51M | |||
| Interest Income/Expense | 918.70K | 429.00K | 20.00K | 20.00K | 80.00K | |||
| Other Income/Expense | N/A | N/A | N/A | 0.00 | 120.00K | |||
| Income Before Taxes | -16.57M | -8.40M | -10.52M | -9.10M | -6.30M | |||
| Net Income | -16.57M | -8.40M | -10.52M | -9.10M | -6.30M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.46 | -0.61 | -0.83 | -0.73 | -0.58 | |||
| Non GAAP EPS | -4.00 | -3.05 | -4.15 | -3.70 | -2.95 | |||
| Statistics | ||||||||
All data in USD